HighLife SAS, a medtech company focused on the development of a unique trans- catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment …
HighLife SAS, a medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment of …
This financing allows for the acceleration of the company’s clinical and R&D program HighLife SAS, an early-stage medtech company focused on the development of a unique trans-catheter mitral valve replacement …
